MICS IOLs better than conventional IOLs

Article

Microincision cataract surgery (MICS) intraocular lenses (IOLs) provide better patient outcomes, which are more like refractive surgery in terms of reduced postoperative astigmatism and minimal induced aberrations, according to a French study.

Microincision cataract surgery (MICS) intraocular lenses (IOLs) provide better patient outcomes, which are more like refractive surgery in terms of reduced postoperative astigmatism and minimal induced aberrations, according to a French study.

Danielle Deidier from Clinic St Vincent, Toulon, France conducted a prospective study of 400 eyes undergoing bimanual MICS. Three hundred eyes received the Akreos MI60, 50 eyes received the Microslim (Physiol) and 50 the Quatrix (Corneal) through a 1.7 mm incision. Aberrometry and higher order aberrations were measured preoperatively and at one week, one month and three months postoperatively.

All three lenses demonstrated good stability within the capsular bag, in addition to good uncorrected visual acuity and best corrected visual acuity results. Low levels of induced astigmatism were recorded and endothelial cell counts were also good.

It was the conclusion of this study that MICS IOLs offer better patient outcomes than conventional lenses.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.